Posted by D. Daniel Sokol See here.
Read more detail on Recent Antitrust Posts –
Related posts:
- Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation
- AALS Annual Meeting, Section on Antitrust and Economic Regulation Presents – Drug Wars: The Battle Over Generic Pharmaceuticals
- Report on Competition Issues in the Norwegian Software Market
- OECD Competition Division Openings in Mexico City
- Valencia: Larbre Competition qualifying report (Motorsport.com)
- FTC Seeks Comments on Study on Authorized Generic Drugs
- NY Times Editorial Comes Out Against DOJ Section 2 Report and DOJ Antitrust Division
- Section 2 and the Section 2 Report
- GNSO New TLDs Committee Draft Final Report -Introduction of Generic Top Level Domains
- GNSO new TLDs Committee Draft Final Report on the Introduction of New Generic Top-Level Domains (gTL